Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases-Reference-Cited by-同舟云学术

Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases

Published:2017-04-24 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Fukuzawa Taku,Sampei Zenjiro,Haraya Kenta,Ruike Yoshinao,Shida-Kawazoe Meiri,Shimizu Yuichiro,Gan Siok Wan,Irie Machiko,Tsuboi Yoshinori,Tai Hitoshi,Sakiyama Tetsushi,Sakamoto Akihisa,Ishii Shinya,Maeda Atsuhiko,Iwayanagi Yuki,Shibahara Norihito,Shibuya Mitsuko,Nakamura Genki,Nambu Takeru,Hayasaka Akira,Mimoto Futa,Okura Yuu,Hori Yuji,Habu Kiyoshi,Wada Manabu,Miura Takaaki,Tachibana Tatsuhiko,Honda Kiyofumi,Tsunoda Hiroyuki,Kitazawa Takehisa,Kawabe Yoshiki^ORCID,Igawa Tomoyuki,Hattori Kunihiro,Nezu Junichi

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-01087-7.pdf

Reference49 articles.

1. Holers, V. M. Complement and its receptors: new insights into human disease. Annual review of immunology 32, 433–459, doi: 10.1146/annurev-immunol-032713-120154 (2014).

2. Serruto, D., Rappuoli, R., Scarselli, M., Gros, P. & van Strijp, J. A. Molecular mechanisms of complement evasion: learning from staphylococci and meningococci. Nature reviews. Microbiology 8, 393–399, doi: 10.1038/nrmicro2366 (2010).

3. Merle, N. S., Church, S. E., Fremeaux-Bacchi, V. & Roumenina, L. T. Complement System Part I - Molecular Mechanisms of Activation and Regulation. Frontiers in immunology 6, 262, doi: 10.3389/fimmu.2015.00262 (2015).

4. Wang, Y. et al. Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proceedings of the National Academy of Sciences of the United States of America 93, 8563–8568, doi: 10.1073/pnas.93.16.8563 (1996).

5. McHarg, S., Clark, S. J., Day, A. J. & Bishop, P. N. Age-related macular degeneration and the role of the complement system. Molecular immunology 67, 43–50, doi: 10.1016/j.molimm.2015.02.032 (2015).

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complement‐targeted therapeutics: Are we there yet, or just getting started?;European Journal of Immunology;2024-09-12

2. The complement model disease paroxysmal nocturnal hemoglobinuria;European Journal of Immunology;2024-08-05

3. Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor‐experienced patients with paroxysmal nocturnal hemoglobinuria;American Journal of Hematology;2024-06-25

4. Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition;American Journal of Hematology;2024-06-17

5. Is the Complement System Dysregulated in Preeclampsia Comorbid with HIV Infection?;International Journal of Molecular Sciences;2024-06-05